I wonder if this "data analysis conclusion" held up the FDA data submission and meeting, and its BTD verdict. (I think the clock starts upon submission: 60 days for BTD decision.) Company doesn't say here. We do know from March that the company was still "preparing for an FDA meeting", pulling together the CSR and a briefing package.